{"id":1493,"date":"2022-11-21T12:17:51","date_gmt":"2022-11-21T18:17:51","guid":{"rendered":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/?p=1493"},"modified":"2022-12-13T11:21:16","modified_gmt":"2022-12-13T17:21:16","slug":"monoclonal-antibodies-may-no-longer-be-a-match-for-emerging-covid-strains","status":"publish","type":"post","link":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/2022\/11\/21\/monoclonal-antibodies-may-no-longer-be-a-match-for-emerging-covid-strains\/","title":{"rendered":"Monoclonal Antibodies May No Longer Be a Match for Emerging COVID Strains"},"content":{"rendered":"<div class=\"panel body-content\"><div class=\"panel__container\">\n<p>(<a href=\"https:\/\/www.medpagetoday.com\/infectiousdisease\/covid19\/101833?xid=nl_mpt_DHE_2022-11-18&amp;eun=g1462072d0r&amp;utm_source=Sailthru&amp;utm_medium=email&amp;utm_campaign=Daily%20Headlines%20Evening%202022-11-18&amp;utm_term=NL_Daily_DHE_dual-gmail-definition\">MedPageToday<\/a>) Evusheld, bebtelovimab losing potency as circulation of BQ.1, BQ.1.1 grows. Tixagevimab\/cilgavimab (Evusheld) and bebtelovimab are likely ineffective against approximately 60% of currently circulating Omicron variants, creating a big gap in protection, particularly for immunocompromised individuals, researchers from a Harvard Medical School-led consortium said at a briefing on late last week.<\/p>\n<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>(MedPageToday) Evusheld, bebtelovimab losing potency as circulation of BQ.1, BQ.1.1 grows. Tixagevimab\/cilgavimab (Evusheld) and bebtelovimab are likely ineffective against approximately 60% of currently circulating Omicron variants, creating a big gap in protection, particularly for immunocompromised individuals, researchers from a Harvard Medical School-led consortium said at a briefing on late last week.<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[35,14],"tags":[],"class_list":["post-1493","post","type-post","status-publish","format-standard","hentry","category-covid-therapies","category-science-and-tech"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/1493","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/comments?post=1493"}],"version-history":[{"count":1,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/1493\/revisions"}],"predecessor-version":[{"id":1494,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/1493\/revisions\/1494"}],"wp:attachment":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/media?parent=1493"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/categories?post=1493"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/tags?post=1493"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}